Saudi Arabia's Government on 21 Jan 2020, reported a new MERS-CoV case, involving a healthcare worker in Abha, Saudi Arabia.
Earlier this month, health officials in Qatar reported three laboratory-confirmed cases of Middle East respiratory syndrome (MERS-CoV) infection.
Researchers conducted a review of molecular and serological investigations through PubMed and EMBASE from September 2012 to 15 November 2018 to measure sub-clinical or asymptomatic Middle East Respiratory syndrome coronavirus (MERS-CoV) infection within and outside of health care settings.
The United Arab Emirates (UAE) has a confirmed case of Middle East respiratory syndrome (MERS) in a 44-year-old male non-national farmer from Al Ain city.
The global health security community should emphasize the danger of zoonotic disease outbreaks and how those diseases can cross the animal-human species barrier by using Middle East respiratory syndrome coronavirus (MERS-CoV) as an example.
The World Health Organization (WHO) reported 14 Middle East respiratory syndrome (MERS) cases in May.
A novel dual route vaccination using the Middle East respiratory syndrome coronavirus (MERS-CoV) receptor binding domain sub-unit has been developed.
Dromedary camels play a significant part in the circulation and the zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Researchers demonstrated that Bactrian camels are also susceptible to MERS-CoV infection and shed large quantities of infectious virus in nasal secretions.
Researchers analyzed epidemiologic and clinical data of laboratory-confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) cases from eleven healthcare-associated outbreaks in Saudi Arabia and the South Korea between 2015–2017.
About 50 percent of reported laboratory-confirmed infections of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in healthcare settings, with healthcare workers constituting over a third of all secondary infections.